Fiscal year 24 prostate cancer research program program support
Ended Awarded Last action
- Contract number
- HT942524F0186
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $387,843
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 81% obligated
- $481,757.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$72,861 | |
| Funding Only Action | $134,745 | |
| Original award | $325,960 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the Defense Health Agency (DHA) to Leidos, Inc. for Fiscal Year 2024 Prostate Cancer Research Program support services. The contract has a ceiling value of $481,757.01 and a completion date of June 30, 2025. The contract does not have a set-aside designation.
Leidos, Inc. is a global technology and engineering solutions provider that serves multiple federal government sectors, including defense, intelligence, health, and civilian. The company's Leidos Services Operating Segment, doing business as SAIC, is the prime contractor for this award. Leidos Holdings, Inc. is the parent company of Leidos, Inc.
This contract supports the DHA's Prostate Cancer Research Program, which funds research to improve detection, diagnosis, and treatment of prostate cancer. The services provided under this contract likely include program management, technical support, and other administrative tasks to assist with the execution of the research program.
Quick answers
Who was awarded contract HT942524F0186?
HT942524F0186 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 1, 2024.
How much is contract HT942524F0186 worth?
The government has obligated $387,843 on HT942524F0186. Its current value, with exercised options, is $481,757.
Is contract HT942524F0186 an order under another contract?
Yes. HT942524F0186 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942524F0186 competed?
The extent of competition for HT942524F0186 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award